Method for producing peptide hydrazide, peptide amide, and peptide thioester

US10053491B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10053491-B2
Application numberUS-201615146589-A
CountryUS
Kind codeB2
Filing dateMay 4, 2016
Priority dateNov 5, 2013
Publication dateAug 21, 2018
Grant dateAug 21, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An object of the present invention is to provide a method for producing a peptide thioester compound, a peptide hydrazide compound, and a peptide amide compound. The present invention provides a method for producing a peptide hydrazide compound or a peptide amide compound by using a compound represented by Formula (2): wherein R 1 , R 2 , R 3 , and X are as defined in the specification, and using a hydrazine compound or an ammonia compound as a reaction reagent. The present invention also provides a method for producing a peptide thioester compound from the peptide hydrazide compound.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for producing a peptide hydrazide compound of Formula (1): wherein R 1 represents an amino acid residue or a derivative thereof, or a peptide residue or a derivative thereof, the method comprising: (A) reacting a compound of Formula (2a) with an alcohol compound in the presence of a transition metal compound comprising a nickel compound, such that an ester compound of Formula (3) is obtained, wherein R 1 is as defined above, R 2 represents hydrogen or alkyl, R 4 represents an arginine side chain, a lysine side chain, or a histidine side chain, R 5 represents a histidine side chain, R 6 represents a leucine side chain, an isoleucine side chain, a tyrosine side chain, a phenylalanine side chain, an arginine side chain, or a tryptophan side chain, and R 7 represents hydroxyl, amino, hydrazino, or an organic group, wherein R 1 is as defined above, and R 8 represents alkyl; and (B) reacting the ester compound of Formula (3) with a hydrazine compound. 2. The method according to claim 1 , wherein the alcohol compound used in (A) is at least one member selected from the group consisting of methanol, ethanol, and dithiodiethanol. 3. The method according to claim 1 , wherein the transition metal compound further comprises at least one of an iron compound and a palladium compound. 4. The method according to claim 1 , wherein the nickel compound is at least one member selected from the group consisting of nickel chloride, nickel bromide, nickel iodide, and hydrates thereof. 5. The method according to claim 1 , wherein the compound of Formula (2a) is selected from the group consisting of compounds of Formulas (2a-1) to (2a-7): wherein R 1 and R 7 are as defined above; wherein R 1 and R 7 are as defined above; wherein R 1 and R 7 are as defined above; wherein R 1 and R 7 are as defined above; wherein R 1 and R 7 are as defined above; wherein R 1 and R 7 are as defined above; and wherein R 1 and R 7 are as defined above. 6. The method according to claim 1 , further comprising preparing the compound of Formula (2a) by a biological synthesis process. 7. A method for producing a peptide thioester compound represented by Formula (5): wherein R 1 represents an amino acid residue or a derivative thereof, or a peptide residue or a derivative thereof, and R 10 represents optionally substituted alkyl or optionally substituted aryl, the method comprising: step (E) of reacting the peptide hydrazide compound represented by Formula (1) obtained in the production method of claim 1 with a nitrite; and step (F) of reacting an acyl azide compound represented by Formula (6) obtained in step (E): wherein R 1 is as defined above, with a thiol compound. 8. The method for producing a peptide thioester compound according to claim 7 , wherein the starting material compound represented by Formula (2) is prepared using a biological synthesis process.

Assignees

Inventors

Classifications

  • Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms · CPC title

  • Labelling of peptides · CPC title

  • C07K7/06Primary

    having 5 to 11 amino acids · CPC title

  • C07K1/107Primary

    by chemical modification of precursor peptides · CPC title

  • by transforming the C-terminal amino acid to amides · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10053491B2 cover?
An object of the present invention is to provide a method for producing a peptide thioester compound, a peptide hydrazide compound, and a peptide amide compound. The present invention provides a method for producing a peptide hydrazide compound or a peptide amide compound by using a compound represented by Formula (2): wherein R 1 , R 2 , R 3 , and X are as defined in…
Who is the assignee on this patent?
Ajinomoto Kk
What technology area does this patent fall under?
Primary CPC classification C07K7/06. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 21 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).